Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics-driven progress in neurodegeneration research.

Michael Fountoulakis1, Sophia Kossida

  • 1Division of Biotechnology, Foundation for Biomedical Research, Academy of Athens, Athens, Greece. mfountoulakis@bioacademy.gr

Electrophoresis
|March 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling Desmin's Head Domain Structure and Function.

Cells·2024
Same author

Molecular fusion events in carcinogenic organisms: a bioinformatics study for the detection of fused proteins between viruses, bacteria and eukaryotes.

EMBnet.journal·2022
Same author

A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses.

Journal of molecular biochemistry·2019
Same author

The Protein Profile of the Human Immature T-cell Line CCRF-CEM.

Cancer genomics & proteomics·2019
Same author

Proteomic Analysis of Liver from Transgenic Mice Overexpressing Small Heterodimer Partner.

Cancer genomics & proteomics·2019
Same author

Ebola virus epidemic: a deliberate accident?

Journal of molecular biochemistry·2018
Same journal

Optimisation of Electrokinetic Extraction System: Colourimetric Determination of Copper (II) in Sand Using Polymer Inclusion Membrane.

Electrophoresis·2026
Same journal

Novel Phloroglucinol Derivatives as Neuraminidase Inhibitors Identified From Humulus lupulus L. Extract by At-Line Nanofractionation Platform.

Electrophoresis·2026
Same journal

Protein-Based High-Performance Liquid Chromatography and Cyclodextrin-Capillary Electrokinetic Chromatography for the Chiral Separation of Azoles.

Electrophoresis·2026
Same journal

Dynamics of Heparin Translocations Through Solid-State Nanopores.

Electrophoresis·2026
Same journal

Production of Protein Hydrolysates and Bioactive Peptides From Lablab purpureus and Macrotyloma uniflorum via Optimized Extraction and Proteolysis Protocols.

Electrophoresis·2026
Same journal

CMOS Electrokinetic Systems and Fabrication Approaches for On-CMOS 3D Electrodes.

Electrophoresis·2026
See all related articles

Proteomics reveals over 330 proteins with altered levels and modifications in neurodegenerative and psychiatric disorders. These findings aid in understanding disease mechanisms and identifying potential biomarkers for conditions like Alzheimer's and Parkinson's disease.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genomics

Background:

  • Neurodegenerative and psychiatric disorders are complex diseases.
  • Proteomics offers a powerful approach to investigate these conditions at a molecular level.
  • Understanding protein changes is crucial for diagnosing and treating these disorders.

Purpose of the Study:

  • To summarize the contributions of proteomics in studying neurodegenerative and psychiatric diseases.
  • To highlight the detection of altered protein levels and modifications in affected individuals.
  • To identify key proteins and pathways implicated in these disorders.

Main Methods:

  • Proteomic analysis of brain and cerebrospinal fluid (CSF) samples.
  • Utilizing techniques like 2-DE and MALDI-TOF-MS for protein quantification and modification detection.

Related Experiment Videos

  • Analyzing samples from patients with Alzheimer's disease, Parkinson's disease, schizophrenia, and animal models.

    • Main Results:

    • Over 330 unique proteins identified with altered levels or modifications.
    • These proteins are primarily involved in metabolism, cytoskeleton, signal transduction, and transport pathways.
    • Proteomics successfully detected differences between healthy individuals and patients.

    Conclusions:

    • Proteomics is instrumental in advancing the understanding of neurodegenerative and psychiatric disorders.
    • Identified proteins serve as potential biomarkers and targets for therapeutic interventions.
    • Continued proteomic research will further elucidate disease mechanisms and facilitate biomarker discovery.